Literature DB >> 16871370

Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

Federico Lara-Villoslada1, Oscar de Haro, Desire Camuesco, Mónica Comalada, Javier Velasco, Antonio Zarzuelo, Jordi Xaus, Julio Galvez.   

Abstract

Previous studies have demonstrated the anti-inflammatory effect of fructooligosaccharides (FOS) on intestinal inflammation. The aim of the present study was to elucidate whether the colonic fermentation of these carbohydrates is a pre-requisite for this anti-inflammatory activity.With this aim short chain-FOS (SC-FOS) were used for an in vitro fermentation to elucidate the time of fermentation of these compounds. For the in vivo experiments female Wistar rats were fed several diets with different sources of fibre (5 g/kg): cellulose for control rats (n = 30) or SC-FOS (n = 20) with a high content of kestose (GF(2)) for the SC-FOS group. After one month of feeding the different diets 10 rats from each group were sacrificed to analyze cecal and colonic microflora, SCFA production and pH of intestinal contents. A distal colonic inflammation was induced to other 10 rats from each group by the administration of 10 mg of TNBS dissolved in 0.25 ml of 50% ethanol (v/v). The rest of the rats from the control group (n = 10) were rendered healthy. One week after TNBS treatment rats were sacrificed and several inflammatory parameters as well as intestinal microbiota and SCFA contents were analyzed. In vitro fermentation experiments showed that SC-FOS are fermented during the first 12 h after incorporating the oligosaccharides to intestinal contents, thus suggesting a preferential fermentation of these carbohydrates in the ileum and cecum. In fact, SC-FOS increased cecal lactobacilli and bifidobacteria counts as well as SCFA production in healthy rats. In colitic rats, SC-FOS feeding caused a decrease of MPO activity, leukotriene B4 (LTB4) production and iNOS expression. This anti-inflammatory effect was evidenced macroscopically by a significant reduction in the extent of colonic damage. SC-FOS also promoted a more favorable intestinal microbiota, increasing lactobacilli and bifidobacteria counts. In conclusion, although oligosaccharides are preferentially fermented in the upper parts of the large intestine, its prebiotic effect is extended to the distal colonic segments, thus exerting a positive effect on colonic inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871370     DOI: 10.1007/s00394-006-0610-2

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  24 in total

Review 1.  The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health.

Authors:  H Hidaka; M Hirayama; T Tokunaga; T Eida
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

2.  Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats.

Authors:  J M Campbell; G C Fahey; B W Wolf
Journal:  J Nutr       Date:  1997-01       Impact factor: 4.798

3.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

4.  Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.

Authors:  Maria Elena Rodríguez-Cabezas; Julio Gálvez; Maria Dolores Lorente; Angel Concha; Desirée Camuesco; Shamira Azzouz; Antonio Osuna; Luis Redondo; Antonio Zarzuelo
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

5.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Authors:  A Macpherson; U Y Khoo; I Forgacs; J Philpott-Howard; I Bjarnason
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

6.  Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.

Authors:  Laura Peran; Desiree Camuesco; Monica Comalada; Ana Nieto; Angel Concha; Maria Paz Diaz-Ropero; Monica Olivares; Jordi Xaus; Antonio Zarzuelo; Julio Galvez
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

7.  Apparent ileal and total-tract nutrient digestion by pigs as affected by dietary nondigestible oligosaccharides.

Authors:  J G Houdijk; M W Bosch; S Tamminga; M W Verstegen; E B Berenpas; H Knoop
Journal:  J Anim Sci       Date:  1999-01       Impact factor: 3.159

8.  Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis.

Authors:  Noëlle M Moreau; Lucile J Martin; Claire S Toquet; Christian L Laboisse; Patrick G Nguyen; Brigitte S Siliart; Henri J Dumon; Martine M J Champ
Journal:  Br J Nutr       Date:  2003-07       Impact factor: 3.718

9.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

10.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

View more
  20 in total

Review 1.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

Review 2.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

Review 3.  Gut microbiota and probiotics in colon tumorigenesis.

Authors:  Yuanmin Zhu; T Michelle Luo; Christian Jobin; Howard A Young
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

4.  In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp.

Authors:  Louise Kristine Vigsnæs; Jesper Holck; Anne S Meyer; Tine Rask Licht
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

5.  Fructooligosaccharide intake promotes epigenetic changes in the intestinal mucosa in growing and ageing rats.

Authors:  Glaucia Carielo Lima; Vivian Cristine Correa Vieira; Cinthia Baú Betim Cazarin; Rafaela da Rosa Ribeiro; Stanislau Bogusz Junior; Cibele Lima de Albuquerque; Ramon Oliveira Vidal; Claudia Cardoso Netto; Áureo Tatsumi Yamada; Fabio Augusto; Mário Roberto Maróstica Junior
Journal:  Eur J Nutr       Date:  2017-03-21       Impact factor: 5.614

6.  Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats.

Authors:  Hiroyuki Ito; Hiroki Tanabe; Hirokazu Kawagishi; Wada Tadashi; Tomono Yasuhiko; Kimio Sugiyama; Shuhachi Kiriyama; Tatsuya Morita
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 7.  The interplay between fiber and the intestinal microbiome in the inflammatory response.

Authors:  Shiu-Ming Kuo
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

Review 8.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

9.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

10.  A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.

Authors:  Tessa M Andermann; Farnaz Fouladi; Fiona B Tamburini; Bita Sahaf; Ekaterina Tkachenko; Courtney Greene; Matthew T Buckley; Erin F Brooks; Haley Hedlin; Sally Arai; Crystal L Mackall; David Miklos; Robert S Negrin; Anthony A Fodor; Andrew R Rezvani; Ami S Bhatt
Journal:  Transplant Cell Ther       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.